The Potential Cost and Benefits of Raltegravir in Simplified Second-Line Therapy among HIV Infected Patients in Nigeria and South Africa

BACKGROUND: There is an urgent need to improve the evidence base for provision of second-line antiretroviral therapy (ART) following first-line virological failure. This is particularly the case in Sub-Saharan Africa where 70% of all people living with HIV/AIDS (PHA) reside. The aim of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Karen, Nwizu, Chidi, Kaplan, Richard, Anderson, Jonathan, Wilson, David P., Emery, Sean, Cooper, David A., Boyd, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574122/
https://www.ncbi.nlm.nih.gov/pubmed/23457450
http://dx.doi.org/10.1371/journal.pone.0054435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574122/
https://www.ncbi.nlm.nih.gov/pubmed/23457450
http://dx.doi.org/10.1371/journal.pone.0054435

Ejemplares similares